Is ERUS or JNJ a better dividend investment in 2026?

ERUS currently yields 43.19% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ERUS offers higher current income.

What is the dividend yield difference between ERUS and JNJ?

ERUS has a forward dividend yield of 43.19% ($3.48/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 39.83 percentage points.

Home › Compare › ERUS vs JNJ

ERUS vs JNJ: Dividend Comparison 2026

ERUS yields 43.19% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ERUS wins by $255.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ERUS

● Live price

43.19%

Share price

$8.06

Annual div

$3.48

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$275.5K

Annual income

$49,605.88

Full ERUS calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ERUS vs JNJ

📍 ERUS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ERUS	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ERUS + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ERUS pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERUS

Annual income on $10K today (after 15% tax)

$3,671.50/yr

After 10yr DRIP, annual income (after tax)

$42,165.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ERUS beats the other by $41,461.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERUS + JNJ for your $10,000?

ERUS: 50%JNJ: 50%

100% JNJ50/50100% ERUS

Portfolio after 10yr

$147.8K

Annual income

$25,216.83/yr

Blended yield

17.06%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ERUS

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERUS buys

JNJ buys

No recent congressional trades found for ERUS or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricERUSJNJ

Forward yield	43.19% ✓	3.36%
Annual dividend / share	$3.48	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$275.5K ✓	$20.0K
Annual income after 10y	$49,605.88 ✓	$827.78
Total dividends collected	$211.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ERUS vs JNJ ($10,000, DRIP)

Year	ERUS Portfolio	ERUS Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$15,019	$4,319.42	$10,676	$355.77	+$4.3K → ERUS
2	$22,134	$6,063.10	$11,407	$389.39	+$10.7K → ERUS
3	$32,034	$8,350.55	$12,198	$426.53	+$19.8K → ERUS
4	$45,571	$11,294.89	$13,056	$467.62	+$32.5K → ERUS
5	$63,778	$15,016.86	$13,987	$513.12	+$49.8K → ERUS
6	$87,884	$19,641.57	$14,998	$563.56	+$72.9K → ERUS
7	$119,331	$25,294.83	$16,098	$619.52	+$103.2K → ERUS
8	$159,783	$32,098.93	$17,295	$681.69	+$142.5K → ERUS
9	$211,136	$40,168.41	$18,599	$750.82	+$192.5K → ERUS
10	$275,521	$49,605.88	$20,022	$827.78	+$255.5K → ERUS

ERUS vs JNJ: Complete Analysis 2026

ERUS — Stock

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large- and mid-capitalization segments of the Russian equity market. The fund is non-diversified.

Full ERUS Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ERUS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERUS vs SCHD ERUS vs JEPI ERUS vs O ERUS vs KO ERUS vs MAIN ERUS vs ABBV ERUS vs MRK ERUS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.